GD2
Disialoganglioside expressed in neuroblastoma and other tumors. Targeted by dinutuximab and naxitamab (approved); GD2 CAR-T in clinical trials.
No Drugs found for this biomarker.
Disialoganglioside expressed in neuroblastoma and other tumors. Targeted by dinutuximab and naxitamab (approved); GD2 CAR-T in clinical trials.
No Drugs found for this biomarker.